1188 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HEPATITIS C GENOTYPE 1: FINAL REPORT

Journal of Hepatology ◽

10.1016/s0168-8278(10)61189-0 ◽

2010 ◽

Vol 52 ◽

pp. S461 ◽

Cited By ~ 3

Author(s):

M.L. Shiffman ◽

A. Ahmed ◽

I.M. Jacobson ◽

R.E. Pruitt ◽

E.B. Keeffe

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Final Report ◽

Phase 2 ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Peginterferon Alfa

Download Full-text

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

Journal of Hepatology ◽

10.1016/j.jhep.2005.09.015 ◽

2006 ◽

Vol 44 (2) ◽

pp. 275-282 ◽

Cited By ~ 47

Author(s):

Peter Ferenci ◽

Elisabeth Formann ◽

Hermann Laferl ◽

Michael Gschwantler ◽

Franz Hackl ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide Plus Peginterferon and Ribavirin in Naïve Patients With Chronic Hepatitis C Genotype 1 Infection: Final Report

Gastroenterology ◽

10.1053/j.gastro.2010.05.067 ◽

2010 ◽

Vol 139 (1) ◽

pp. e18 ◽

Cited By ~ 4

Author(s):

Bruce R. Bacon ◽

Mitchell L. Shiffman ◽

Joseph K. Lim ◽

Arthur Berman ◽

Vinod K. Rustgi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase Ii ◽

Controlled Study ◽

Final Report ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Peginterferon And Ribavirin

Download Full-text

Faculty Opinions recommendation of Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952635.793458150 ◽

2012 ◽

Author(s):

Alex Thompson

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Dose Finding ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

Liver International ◽

10.1111/liv.12300 ◽

2013 ◽

Vol 34 (5) ◽

pp. 707-719 ◽

Cited By ~ 12

Author(s):

Michael P. Manns ◽

Jonathan McCone ◽

Mitchell N. Davis ◽

Lorenzo Rossaro ◽

Eugene Schiff ◽

...

Keyword(s):

Clinical Trials ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Safety Profile ◽

Phase 2 ◽

Genotype 1 ◽

Combined Analysis ◽

Peginterferon Alfa

Download Full-text

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

Journal of Hepatology ◽

10.1016/j.jhep.2004.11.025 ◽

2005 ◽

Vol 42 (3) ◽

pp. 315-322 ◽

Cited By ~ 171

Author(s):

Nizar N. Zein ◽

for the Etanercept Study Group

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Study ◽

Phase 2 ◽

Hepatitis C Virus Infection ◽

Double Blind ◽

Double Blind Placebo ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718367975.793494877 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Clinical Trials ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Safety Profile ◽

Phase 2 ◽

Genotype 1 ◽

Combined Analysis ◽

Peginterferon Alfa

Download Full-text

1059 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HCV GENOTYPE 1: WEEK 28 INTERIM ANALYSIS

Journal of Hepatology ◽

10.1016/s0168-8278(09)61061-8 ◽

2009 ◽

Vol 50 ◽

pp. S385-S386 ◽

Cited By ~ 5

Author(s):

M. Shiffman ◽

A. Ahmed ◽

I. Jacobson ◽

R. Pruitt ◽

E. Keeffe

Keyword(s):

Interim Analysis ◽

Controlled Study ◽

Phase 2 ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Download Full-text

Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study

Gut ◽

10.1136/gut.2007.131607 ◽

2007 ◽

Vol 57 (4) ◽

pp. 531-536 ◽

Cited By ~ 74

Author(s):

M R Kraus ◽

A Schafer ◽

K Schottker ◽

C Keicher ◽

B Weissbrich ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Yearbook of Gastroenterology ◽

10.1016/j.ygas.2011.07.125 ◽

2011 ◽

Vol 2011 ◽

pp. 243-245

Author(s):

D.M. Harnois

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Dose Escalation ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Polymerase Inhibitor

Download Full-text

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(12)70138-x ◽

2012 ◽

Vol 12 (9) ◽

pp. 671-677 ◽

Cited By ~ 110

Author(s):

Stanislas Pol ◽

Reem H Ghalib ◽

Vinod K Rustgi ◽

Claudia Martorell ◽

Greg T Everson ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Dose Finding ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text